Will the TRANSFORM II trial transform our management of small vessel coronary disease?
Catheter Cardiovasc Interv
.
2022 Nov;100(5):925-926.
doi: 10.1002/ccd.30429.
Epub 2022 Oct 18.
Authors
Cindy L Grines
1
,
Pradyumna Tummala
1
Affiliation
1
Northside Hospital Cardiovascular Institute, Atlanta, Georgia, USA.
PMID:
36255037
DOI:
10.1002/ccd.30429
No abstract available
Keywords:
ATH - atherosclerosis; PCI - percutaneous coronary intervention; drug coated/eluting.
Publication types
Comment
MeSH terms
Clinical Trials as Topic
Coronary Artery Disease* / therapy
Humans